tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Aspira Women’s Health Raises $3.06 Million in Funding

Story Highlights
  • Aspira raised $2.95 million through a private placement of common stock and warrants.
  • The capital will support Aspira’s growth and strategic goals in women’s health diagnostics.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Aspira Women’s Health Raises $3.06 Million in Funding

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Aspira Women’s Health ( (AWHL) ) has shared an update.

On September 16, 2025, Aspira Women’s Health Inc. entered into securities purchase agreements with investors, resulting in a private placement of common stock and warrants, raising approximately $2.95 million. The company plans to use these funds for working capital and general corporate purposes. This financial move, along with an additional $112,500 from warrant exercises, provides Aspira with a total equity capital infusion of $3.06 million. This capital will support Aspira’s ongoing commercial activities and growth plans, as the company focuses on executing its strategic goals and expanding its innovative product pipeline in women’s health diagnostics.

The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.

Spark’s Take on AWHL Stock

According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.

The company’s challenging financial position, marked by unprofitability and negative equity, significantly impacts its stock score. While technical indicators show some positive momentum, the lack of profitability and adverse corporate events weigh heavily on the overall assessment.

To see Spark’s full report on AWHL stock, click here.

More about Aspira Women’s Health

Aspira Women’s Health Inc. is a company focused on the discovery, development, and commercialization of noninvasive, AI-powered tests for diagnosing gynecologic diseases. Their products, such as OvaWatch® and Ova1Plus®, are part of the OvaSuiteSM, which offers blood tests to help detect ovarian cancer risk in women with adnexal masses. Aspira is also developing tests for endometriosis, aiming to enhance diagnostic capabilities using microRNA and protein biomarkers.

Average Trading Volume: 101,602

Technical Sentiment Signal: Sell

Current Market Cap: $14.8M

For an in-depth examination of AWHL stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1